publication date: Feb. 13, 2015

Deisseroth Awarded Lurie Prize For Cell and Tissue Imaging


KARL DEISSEROTH was awarded the Lurie Prize in Biomedical Sciences for the development of tools to image the functions of cells, especially neurons.

Deisseroth is being recognized by the Foundation for the NIH for leading the development of optogenetics, a technology for controlling cells with light to determine function, as well as for CLARITY, a method for transforming intact organs into transparent polymer gels to allow visualization of biological structures with high resolution and detail. The prize will be presented to Deisseroth May 20 in Washington, D.C.

Deisseroth is the D.H. Chen Professor of Bioengineering and of Psychiatry and Behavioral Sciences at Stanford University and a Howard Hughes Medical Institute Investigator. He first pioneered the field of optogenetics, which has greatly expanded our understanding of normal behavior as well as of diseases like Parkinson’s, schizophrenia and depression, by combining genetic manipulation and optics to activate or deactivate precisely targeted brain cells.

His team also pioneered CLARITY, a chemical engineering method for making biological tissues such as the intact brain fully transparent and accessible, and which has already enabled scientists to observe intricate molecular-resolution details within healthy brains as well as brains from Alzheimer’s disease and autism patients.

“We are delighted to bestow the Lurie Prize to Dr. Deisseroth for his revolutionary work studying the complex circuitry and function of the brain,” said Maria Freire, president and executive director of the FNIH. “Today’s outstanding biomedical advances, such as optogenetics and CLARITY, will make their way into standard laboratory practice and ultimately help to alleviate human suffering.”

A member of the National Academy of Sciences and the Institute of Medicine, … Continue reading 41-06 Deisseroth Awarded Lurie Prize For Cell and Tissue Imaging

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.